Cellectis S.A

Short Term Long Term Short Term Comparison Long Term Comparison
  • ALCLS
  • 1d-5.95%
  • 1w-6.14%
  • 1m1.37%
  • 1y26.13%
ATH
  • ATH Price$40.90
  • ATH Date2015-05-29
  • % since ATH-94.21%
  • % to ATH1,625.74%
ATL
  • ATL Price$0.90
  • ATL Date2023-10-31
  • % from ATL163.33%
  • Last Low Price$0.9
  • Last Low Date2023-10-31
  • % From Last Low163.33%
IPO
  • IPO Price$29.52
  • % Current ROI USD-91.97%
  • ATH Price$40.90
  • % ROI ATH 454,444.44%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="ALCLS"]

Key Data [addtoany]

Current price $2.37
Sector Healthcare
Industry Biotechnology
Today's High/Low $2.47/$2.3
Volume 219,003.00
Previous Close $2.52
52 Week High/Low $3.44/$0.888
Market Cap 181,322,832.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $-1.14
Annualized Dividend $0
$2.37
[addtoany]
Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity